We believe Perrigo is in fine financial health. At the end of 2024, the company had roughly $560 million in cash and equivalents with about $3.3 billion in long-term debt. Its balance sheet was in a ...

New emerging life sciences hubs are gaining ground amid the market shift.

J&J's stock price is down from its 2022 peak, but it's performed better than you might think by simply looking at its chart.

After years of post-COVID-19 normalization and the impact of its Kenvue spinoff, Johnson & Johnson’s (NYSE: JNJ) stock price ...

What a bunch of babies!” That was my reaction when, as an ardent believer in technical analysis over narratives, meme stocks, and Federal Reserve mania, I read that market expectations for a Fed rate ...

Bitmine Immersion Technologies (BMNR) is up more than 20% in afternoon trading after billionaire investor Peter Thiel ...

In a testament to its enduring strength and adaptive strategy, Johnson & Johnson (NYSE: JNJ) today announced a strong ...

Shoppers aged 45 to 60 now make up 25% of total spend for the beauty category, favouring products that ‘balance benefits with ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $23.58, a high estimate of $25.00, ...

Analysts expect Johnson & Johnson to report an earnings per share (EPS) of $2.67. Johnson & Johnson bulls will hope to hear ...

Real-time index price for TSX Composite Index (TXCX), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

“The Board’s strategic review is underway, and we are considering a broad range of potential alternatives, including ways to ...